NasdaqCM - Nasdaq Real Time Price USD

SeaStar Medical Holding Corporation (ICU)

Compare
1.9900
0.0000
(0.00%)
At close: January 10 at 4:00:02 PM EST
1.9774
-0.01
(-0.63%)
After hours: 7:39:42 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Eric Schlorff CEO, President & Executive Director 420k -- 1973
Colonel Kevin Chung FACP, M.D. Chief Medical Officer 350k -- 1973
Dr. H. David Humes M.D. Co-Founder and Managing Director 135.71k -- --
Mr. David A. Green CPA, M.B.A. Chief Financial Officer -- -- 1963
Tom Mullen Vice President of Operations & Product Development -- -- --
Mr. Tim Varacek Senior VP of Commercial & Business Operations -- -- --
Sai P. Iyer Senior Vice President of Medical Affairs & Research -- -- --

SeaStar Medical Holding Corporation

3513 Brighton Boulevard
Suite 410
Denver, CO 80216
United States
844 427 8100 https://www.seastarmedical.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
12

Description

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Corporate Governance

SeaStar Medical Holding Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 13, 2024 at 10:05 PM UTC

SeaStar Medical Holding Corporation Earnings Date

Recent Events

December 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 19, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 27, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

November 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 4, 2024 at 12:00 AM UTC

DEF 14A: Proxy Statements

October 24, 2024 at 12:00 AM UTC

PRE 14A: Proxy Statements

October 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 23, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

August 21, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers